Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Biomimetic and Functional Nanomaterials for Molecular Imaging"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 16704
Special Issue Editors
Interests: MRI; fMRI; molecular imaging; nanotechnology; biomaterials; contrast agents; theranostics; drug delivery; neuroiscience; neurodegeneration; cerebrovascular diseases
Interests: MRI; molecular imaging; nanotechnology; biomaterials; contrast agents; theranostics; pulmonary and cardiovascular imaging; pulmonary hypertension; artheriosclerosis
Special Issue Information
The development of imaging technologies that allow non-invasively scrutinizing a body’s interior has represented a breakthrough for the diagnosis, the study of mechanisms of action, and novel therapeutic approaches against disease . In recent years, the development of novel biomaterials and the use of nanotechnology has helped to introduce new medical imaging technologies. Transcending the mere acquisition of images and becoming a genuinely molecular imaging discipline, nanotechnology has brought increased sensitivity, high selectivity to imaging targets, sensitivity to function, and the combination of therapeutic and diagnostic functions in common molecular platforms (a discipline named theranostics). Thus, combining nanotechnology and imaging technologies such as Magnetic resonance Imaging, X-ray computerized tomography, positron emission tomography, ultrasound imaging, and others, the field of molecular imaging is emerging as a multidisciplinary key enabling technology in the field of biomedicine.
Because of the broad range of applications of biomaterials developed during the last years, with important implications in biomedical research, in general, and in the field of molecular imaging, in particular, this Special Issue aims to collect relevant research or review articles that provide evidence of the state of art in the assessment and recent technological breakthrough in biomaterials, their function and applications in the field of molecular imaging.
Prof. Dr. Pedro Ramos-Cabrer
Prof. Dr. Jesus Ruiz-Cabello
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- biomimetic materials
- functional biomaterials
- contrast agents
- controlled drug release
- smart drug delivery
- ultrasound imaging
- X-ray computed tomography
- magnetic resonance imaging
- single photon emission computer tomography
- positron emission tomography
- optical imaging